Definitive chemoradiotherapy with simultaneous integrated boost of radiotherapy dose for T4 esophageal cancer-will it stand for a standard treatment?

Satoru Matsuda; Shuhei Mayanagi; Tomoyuki Irino; Hirofumi Kawakubo; Yuko Kitagawa

doi:10.21037/jtd.2019.12.59

Definitive chemoradiotherapy with simultaneous integrated boost of radiotherapy dose for T4 esophageal cancer-will it stand for a standard treatment?

Satoru Matsuda, Shuhei Mayanagi, Tomoyuki Irino, Hirofumi Kawakubo, Yuko Kitagawa

研究成果: Editorial › 査読

本文言語	English
ページ（範囲）	5682-5684
ページ数	3
ジャーナル	Journal of Thoracic Disease
巻	11
号	12
DOI	https://doi.org/10.21037/jtd.2019.12.59
出版ステータス	Published - 2019 12月 1

ASJC Scopus subject areas

呼吸器内科

UN SDG

この成果は、次の持続可能な開発目標に貢献しています

文献へのアクセス

10.21037/jtd.2019.12.59

他のファイルとリンク

引用スタイル

@article{b0d2044c03884f5580ba7d4009c53d53,

title = "Definitive chemoradiotherapy with simultaneous integrated boost of radiotherapy dose for T4 esophageal cancer-will it stand for a standard treatment?",

author = "Satoru Matsuda and Shuhei Mayanagi and Tomoyuki Irino and Hirofumi Kawakubo and Yuko Kitagawa",

year = "2019",

month = dec,

day = "1",

doi = "10.21037/jtd.2019.12.59",

language = "English",

volume = "11",

pages = "5682--5684",

journal = "Journal of Thoracic Disease",

issn = "2072-1439",